Shaya Fadia T, Blume Steven, Mullins C Daniel
Center on Drugs and Public Policy at the University of Maryland School of Pharmacy, USA.
Health Aff (Millwood). 2004 Sep-Oct;23(5):226-32. doi: 10.1377/hlthaff.23.5.226.
Out-of-pocket drug spending per patient rose 25 percent in 2001 for the privately insured nonelderly in Maryland, outpacing the 10 percent increase in total drug spending per patient. Prescription drug use patterns changed little in response to a 30 percent rise in copayments, with the number of prescriptions per patient decreasing by 3 percent, and the proportion of generic drugs remaining steady. About 23 percent of patients spent less than 50 dollars on drugs in 2001, while 21 percent spent more than 700 dollars. Findings suggest that a greater proportion of the economic burden of prescription drugs in coming years will be borne by those who use them.
2001年,马里兰州非老年私人保险患者的自付药品费用每人上涨了25%,超过了每位患者药品总支出10%的涨幅。尽管共付额上涨了30%,处方药使用模式变化不大,每位患者的处方数量减少了3%,非专利药的比例保持稳定。2001年,约23%的患者在药品上花费不到50美元,而21%的患者花费超过700美元。研究结果表明,未来几年,处方药经济负担的更大比例将由用药者承担。